ReviewClinical & translational immunology2016

Is the risk of cardiovascular disease altered with anti-inflammatory therapies? Insights from rheumatoid arthritis.

Michael J Kraakman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.